Marinobufagenin interferes with the function of the mineralocorticoid receptor

Marver, 1983, Renal target sites and the mechanism of action of aldosterone, Miner Electrolyte Metab., 9, 1 Mick, 2001, The alpha-subunit of the epithelial sodium channel is an aldosterone-induced transcript in mammalian collecting ducts, and this transcriptional response is mediated via distinct cis-elements in the 5’-flanking region of the gene, Mol. Endocrinol., 15, 575 Kolla, 2000, Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor, Mol. Cell Biochem., 204, 35, 10.1023/A:1007009700377 Schoner, 2002, Endogenous cardiac glycosides, a new class of steroid hormones, Eur. J. Biochem., 269, 2440, 10.1046/j.1432-1033.2002.02911.x Schoner, 2005, Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer, Semin. Nephrol., 25, 343, 10.1016/j.semnephrol.2005.03.010 Bagrov, 1996, Endogenous marinobufagenin-like immunoreactive substance, Am. J. Hypertens, 9, 982, 10.1016/0895-7061(96)00148-3 Vu, 2005, Involvement of marinobufagenin in a rat model of human preeclampsia, Am. J. Nephrol., 25, 520, 10.1159/000088461 Bagrov, 1995, Effects of two endogenous Na+, K+-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta, Eur. J. Pharm., 274, 151, 10.1016/0014-2999(94)00735-P Fedorova, 2001, Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats, Hypertension, 37, 462, 10.1161/01.HYP.37.2.462 Raymond, 1987, Efferent limb of volume homeostasis, 33 Hall, 1987, Role of angiotensin and aldosterone in volume homeostasis, 69 Fedorova, 1998, Endogenous marinobufagenin-like factor in acute plasma volume expansion, Clin. Exp. Hypertens, 20, 581, 10.3109/10641969809053236 Bagrov, 1996, Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs, Cardiovasc. Res., 31, 296, 10.1016/S0008-6363(95)00208-1 Gonick, 1998, Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states, Clin. Exp. Hypertens, 20, 617, 10.3109/10641969809053240 Berger, 1998, Mineralocorticoid receptor knock-out mice: pathophysiology of Na+ metabolism, Proc. Natl. Acad. Sci. USA, 95, 9424, 10.1073/pnas.95.16.9424 Arriza, 1987, Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor, Science, 237, 268, 10.1126/science.3037703 Nawaz, 1999, Proteasome-dependent degradation of the human estrogen receptor, Proc. Natl. Acad. Sci. USA, 96, 1858, 10.1073/pnas.96.5.1858 Wu, 2004, Selective phosphorylations of the SRC-3/AIBI coactivator integrate genomic responses to multiple cellular signaling pathways, Mol.Cell, 15, 937, 10.1016/j.molcel.2004.08.019 Nawaz, 1999, The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily, Mol. Cell. Biol., 19, 1182, 10.1128/MCB.19.2.1182 Walters, 2002, SKF-82958 is a subtype-selective estrogen receptor-α (ERα) agonist that induces functional interactions between ERα and AP-1, J. Biol. Chem., 277, 1669, 10.1074/jbc.M109320200 Ribeiro, 1995, The nuclear Hormone receptor gene superfamily, Ann. Rev. Med., 46, 443, 10.1146/annurev.med.46.1.443 Yokota, 2004, Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone, Endocrine Res., 30, 611, 10.1081/ERC-200043783 Baxter, 2004, Towards selectively modulating mineralocorticoid receptor function: lessons from other systems, Mol. Cell Endocrinol., 217, 151, 10.1016/j.mce.2003.10.044 Nilsson, 2001, Mechanisms of estrogen action, Physiol. Rev., 81, 1535, 10.1152/physrev.2001.81.4.1535 McKenna, 1999, Nuclear receptor coregulators: cellular and molecular biology, Endocr. Rev., 20, 321 Wu, 2005, Transcriptional regulation by steroid receptor coactivator phosphorylation, Endocr. Rev., 26, 393, 10.1210/er.2004-0018 Pamanani, 1991, Effects of three sodium-potassium adenosine triphosphatase inhibitors, Hypertension, 18, 316, 10.1161/01.HYP.18.3.316 Schwartz, 1975, The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects, Pharmacol. Rev., 27, 3 Puschett, 1992, Section 8: renal physiology, 2335 Puschett, 1992, Sites and mechanisms of the renal actions of diuretics in man, 117 Lim-Tio, 1998, Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors, Endocrinology, 139, 1653, 10.1210/endo.139.4.5928 Kotova, 2006, Cardiotonic steroids stimulate glycogen synthesis in ERK1/2-dependent mechanism, J. Biol. Chem., 281, 20085, 10.1074/jbc.M601577200 Alper, 2006, Phenotypic characteristics shared by preeclamptic patients and an animal model of preeclampsia: a pilot study, Am. J. Hypertens, 19, 947, 10.1016/j.amjhyper.2006.04.004 Puschett, 2006, The role of excessive volume expansion in the pathogenesis of preeclampsia, Med. Hypotheses, 67, 1125, 10.1016/j.mehy.2006.04.059